Hasan Rehman1, Ayeesha K Kamal2, Pamela B Morris3, Saleem Sayani4, Anwar T Merchant5,6, Salim S Virani7,8,9. 1. Houston Methodist Hospital, Houston, TX, USA. 2. The Aga Khan University Medical College, Karachi, Pakistan. 3. Medical University of South Carolina, Charleston, SC, USA. 4. Aga Khan Development Network eHealth Resource Centre for Asia and Africa, Karachi, Pakistan. 5. Department of Epidemiology and Biostatistics, Arnold School of Public Health, University of South Carolina, Columbia, SC, USA. 6. WJB Dorn VA Medical Center, Columbia, SC, USA. 7. Section of Cardiology, Michael E. DeBakey Veterans Affairs Medical Center, Houston, TX, USA. virani@bcm.edu. 8. Section of Cardiovascular Research, Department of Medicine, Baylor College of Medicine, Houston, TX, USA. virani@bcm.edu. 9. Health Services Research and Development (152), Michael E. DeBakey Veterans Affairs Medical Center, 2002 Holcombe Blvd., Houston, TX, 77030, USA. virani@bcm.edu.
Abstract
PURPOSE OF REVIEW: Hypertension and hyperlipidemia represent two major risk factors for atherosclerotic cardiovascular disease. Mobile health or mHealth is defined as the use of mobile phone and wireless technologies to support the achievement of health objectives. Management of hypertension, and to some extent hyperlipidemia, has often employed mHealth interventions given lower cost and greater patient engagement compared to traditional methods. These interventions include the use of text messaging, wireless devices, and mobile phone applications. This review considers recent studies evaluating the effectiveness of mHealth interventions in the management of hypertension and hyperlipidemia. RECENT FINDINGS: Numerous studies have evaluated the role of mHealth interventions in the management of hypertension, while very few have evaluated their role in hyperlipidemia. Text messaging has been used most frequently. However, the trend is shifting towards the use of mobile phone applications and wireless devices. Interventions in developing countries have been modified for greater applicability to local settings. mHealth interventions were found to be frequently effective. However, studies comparing the relative efficacy of various mHealth strategies are scarce. Long-term cardiovascular outcomes data and analyses relating to cost effectiveness are also lacking. mHealth interventions may be effective in improving hypertension management. More studies are needed to evaluate the role of mHealth strategies in hyperlipidemia management, particularly in identifying high-risk individuals and improving medication adherence. Studies assessing the long-term impact of these interventions, comparing different interventions and analyzing their relative cost effectiveness, are also needed. Following recently published guidelines on reporting results of mHealth interventions will provide a more meaningful context for interpreting these promising early studies.
PURPOSE OF REVIEW: Hypertension and hyperlipidemia represent two major risk factors for atherosclerotic cardiovascular disease. Mobile health or mHealth is defined as the use of mobile phone and wireless technologies to support the achievement of health objectives. Management of hypertension, and to some extent hyperlipidemia, has often employed mHealth interventions given lower cost and greater patient engagement compared to traditional methods. These interventions include the use of text messaging, wireless devices, and mobile phone applications. This review considers recent studies evaluating the effectiveness of mHealth interventions in the management of hypertension and hyperlipidemia. RECENT FINDINGS: Numerous studies have evaluated the role of mHealth interventions in the management of hypertension, while very few have evaluated their role in hyperlipidemia. Text messaging has been used most frequently. However, the trend is shifting towards the use of mobile phone applications and wireless devices. Interventions in developing countries have been modified for greater applicability to local settings. mHealth interventions were found to be frequently effective. However, studies comparing the relative efficacy of various mHealth strategies are scarce. Long-term cardiovascular outcomes data and analyses relating to cost effectiveness are also lacking. mHealth interventions may be effective in improving hypertension management. More studies are needed to evaluate the role of mHealth strategies in hyperlipidemia management, particularly in identifying high-risk individuals and improving medication adherence. Studies assessing the long-term impact of these interventions, comparing different interventions and analyzing their relative cost effectiveness, are also needed. Following recently published guidelines on reporting results of mHealth interventions will provide a more meaningful context for interpreting these promising early studies.
Entities:
Keywords:
Cardiovascular diseases; Hyperlipidemia; Hypertension; Mobile health; mHealth
Authors: Robert P Nolan; Sam Liu; J Kevin Shoemaker; Vladimir Hachinski; Hazel Lynn; David J Mikulis; Richard A Wennberg; Margaret Moy Lum-Kwong; Ahmad Zbib Journal: Can J Cardiol Date: 2012-04-11 Impact factor: 5.223
Authors: Clara K Chow; Julie Redfern; Graham S Hillis; Jay Thakkar; Karla Santo; Maree L Hackett; Stephen Jan; Nicholas Graves; Laura de Keizer; Tony Barry; Severine Bompoint; Sandrine Stepien; Robyn Whittaker; Anthony Rodgers; Aravinda Thiagalingam Journal: JAMA Date: 2015 Sep 22-29 Impact factor: 56.272
Authors: Alexander G Logan; M Jane Irvine; Warren J McIsaac; Andras Tisler; Peter G Rossos; Anthony Easty; Denice S Feig; Joseph A Cafazzo Journal: Hypertension Date: 2012-05-21 Impact factor: 10.190
Authors: Anton R Kiselev; Vladimir I Gridnev; Vladimir A Shvartz; Olga M Posnenkova; Pavel Ya Dovgalevsky Journal: J Am Soc Hypertens Date: 2012 Sep-Oct
Authors: Liselotte W Wijsman; Edo Richard; Ricardo Cachucho; Anton Jm de Craen; Susan Jongstra; Simon P Mooijaart Journal: JMIR Mhealth Uhealth Date: 2016-06-13 Impact factor: 4.773
Authors: Tatiana M Davidson; John McGillicuddy; Martina Mueller; Brenda Brunner-Jackson; April Favella; Ashley Anderson; Magaly Torres; Kenneth J Ruggiero; Frank A Treiber Journal: J Pers Med Date: 2015-11-17
Authors: Gloria Too; Timothy Wen; Amelia K Boehme; Eliza C Miller; Lisa R Leffert; Frank J Attenello; William J Mack; Mary E DʼAlton; Alexander M Friedman Journal: Obstet Gynecol Date: 2018-01 Impact factor: 7.661